ALBERT DAVID
Back to Income Statement
|
ALBERT DAVID Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹346 Cr | ₹362 Cr | ₹342 Cr | ₹314 Cr | ₹247 Cr |
What is the latest Revenue of ALBERT DAVID ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹362 Cr |
| Mar2023 | ₹342 Cr |
| Mar2022 | ₹314 Cr |
| Mar2021 | ₹247 Cr |
How is Revenue of ALBERT DAVID Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹346 Cr | -4.61 | |
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | 26.70 | |
| Mar2021 | ₹247 Cr | - | |
Compare Revenue of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹437.6 Cr | 1.5% | -12.4% | -45.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 1.5% |
-12.4% |
-45.9% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses